Evidence map›Paper›PMID 27940689›Full record

ArticlePediatrics2016

School Entry Requirements and Coverage of Nontargeted Adolescent Vaccines.

Jennifer L Moss, Paul L Reiter, Young K Truong, Barbara K Rimer, Noel T Brewer

Open access · bronzeAbstract read
In one paragraph

Article in Pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Pooled it
  4. Trial
  5. Parent, Child, and Provider Perspectives on HPV Vaccination in 4-8-Year-Olds: A Mixed Methods Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Factors Associated With Receipt of Meningococcal B Vaccine Among United States Adolescents, National Immunization Survey-Teen, 2017-2018.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2021
    Article
  10. National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Addressing barriers to vaccine acceptance: an overview.Human vaccines & immunotherapeutics · 2018
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jennifer L MossDepartments of Health Behavior and jennifer.moss@nih.gov.
Paul L ReiterCollege of Medicine, The Ohio State University, Columbus, Ohio.
Young K TruongBiostatistics, Gillings School of Global Public Health, and.
Barbara K RimerDepartments of Health Behavior and.
Noel T BrewerDepartments of Health Behavior and.
UNC Lineberger Comprehensive Cancer CenterThe Ohio State University · US

Funding

Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
Influence of yearly cycles in adolescent vaccination on cancer preventionF31CA189411 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MOSS, JENNIFER LINDSAY · 2014 to 2014
$27k
NCI NIH HHS F31 CA189411NCI NIH HHS T32 CA057726
6 · The paper itself

Abstract

backgroundLow human papillomavirus (HPV) vaccination coverage is an urgent public health problem requiring action. To identify policy remedies to suboptimal HPV vaccination, we assessed the relationship between states' school entry requirements and adolescent vaccination.

methodsWe gathered data on states' school entry requirements for adolescent vaccination (tetanus, diphtheria, and pertussis [Tdap] booster; meningococcal; and HPV) from 2007 to 2012 from Immunization Action Coalition. The National Immunization Survey-Teen provided medical record-verified vaccination data for 99 921 adolescents. We calculated coverage (among 13- to 17-year-olds) for individual vaccinations and concomitant vaccination. HPV vaccination outcomes were among female adolescents. Analyses used weighted longitudinal multivariable models.

resultsStates with requirements for Tdap booster and meningococcal vaccination had 22 and 24 percentage point increases in coverage for these vaccines, respectively, compared with other states (both P < .05). States with HPV vaccination requirements had <1 percentage point increase in coverage for this vaccine (P < .05). Tdap booster and meningococcal vaccination requirements, respectively, were associated with 8 and 4 percentage point spillover increases for HPV vaccination coverage (both P < .05) and with increases for concomitant vaccination (all P < .05).

conclusionsEnsuring all states have meningococcal vaccination requirements could improve the nation's HPV vaccination coverage, given that many states already require Tdap booster but not meningococcal vaccination for school entry. Vaccination programs and clinicians should capitalize on changes in adolescent vaccination, including concomitant vaccination, that may arise after states adopt vaccination requirements. Additional studies are needed on the effects of HPV vaccination requirements and opt-out provisions.

Indexed as

AdolescentAdolescent Health ServicesFemaleHumansImmunization ScheduleMalePapillomavirus VaccinesSchool Admission CriteriaSchoolsUnited StatesVaccinationPapillomavirus Vaccines

Identifiers

PMID27940689
PMCPMC5127065
OpenAlexW2549728526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.